NCI-H1703 Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Lung cancer cell lines

,

NCI cell lines

Organism

Human

Donor History

Lung squamous cell carcinoma

Growth Properties

Adherent

Growth Conditions

Culture medium: RPMI 1640

,

w: 2.0 mM stable Glutamine

,

w: 2.0 g/L NaHCO3 (Cytion article number 820700a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/NCI-H1703-Cells/305090

SKU: 305090 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

NCI-H1703 is a human lung cancer cell line derived from a stage I lung squamous cell carcinoma resected from a 54-year-old male smoker. This line exhibits a squamous epithelial morphology characteristic of lung carcinoma, reflecting its origin in lung tumor tissue:contentReference. It is classified as a non-small cell lung cancer (NSCLC) model, providing researchers with an in vitro representation of the squamous subtype of lung cancer. NCI-H1703 is widely used in lung cancer research, particularly to study the squamous cell subtype of NSCLC:contentReference. It serves as a valuable model for investigating tumor biology and key cellular signaling pathways involved in lung cancer progression:contentReference. Researchers also employ NCI-H1703 to evaluate the efficacy of candidate anti-cancer compounds, including various targeted therapies. Additionally, this cell line can be used to establish xenograft models for preclinical testing of new treatments and to examine mechanisms of drug response and resistance in lung cancer.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.